The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells
Keyword(s):
2010 ◽
Keyword(s):
2009 ◽
Vol 8
(8)
◽
pp. 2221-2231
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 142
(2)
◽
pp. 219-226
◽
Keyword(s):
2017 ◽
Vol 38
(11)
◽
pp. 1512-1520
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 10
(2)
◽
pp. 126-130
Keyword(s):